Related Experiment Video
Updated: May 8, 2026

10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
8.7K
Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review
Ahmed Saad Abdlkadir1, Florian Rosar2, Amireza Jalilian3
1Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Queen Rania Street, Al Jubeiha, Amman, 11942 Jordan.
Nuclear Medicine and Molecular Imaging
|January 30, 2025
Summary
This review highlights the limited clinical research on terbium radioisotopes (Tb), with only 161Tb and 152Tb showing potential. Further clinical trials are needed for nuclear oncology applications.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Oncology
Background:
- Terbium radioisotopes are being explored for medical applications.
- A systematic review was conducted to assess their current practical applications.
Purpose of the Study:
- To systematically review and assess the practical applications of four terbium radioisotopes: 149Tb, 152Tb, 155Tb, and 161Tb.
- To identify the current research status and potential clinical utility of these isotopes.
Main Methods:
- Systematic literature search of PubMed, Web of Science, and Scopus databases.
- Keywords included terbium and its four radioisotopes.
- Search updated to July 27, 2024.
Main Results:
- A total of 429 papers were reviewed after removing duplicates.
- Only nine papers discussed the potential uses of 161Tb and 152Tb.
- 155Tb and 149Tb have not yet been studied in human subjects.
Conclusions:
- Research is shifting towards clinical studies with in-human data for radiotheranostics and nuclear oncology.
- Preliminary findings are encouraging, leading to the initiation of clinical trials.
- Clinical adoption hinges on trial success and production facility establishment.

